NCT00920842
- Conditions
- Bone Marrow Diseases, Cardiovascular Complications, Chronic Disease, +25 more
- Locations
-
- Clinical Research Center - Seattle Children's Hospital Seattle, Washington, United States
Clinical trial condition
Leukemia, Lymphocytic, Chronic, B-Cell
Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.
1,434 public trials
165 recruiting studies
Leukemia, Lymphocytic, Chronic, B-Cell trial results
NCT00513175
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +61 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
NCT00004002
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT00005622
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +56 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
NCT00003143
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
NCT00255749
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +64 more
- Locations
-
- Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
NCT00296023
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +64 more
- Locations
-
- Alta Bates Comprehensive Cancer Center Berkeley, California, United States
- UCSF Comprehensive Cancer Center San Francisco, California, United States
NCT00787761
- Conditions
- Adenocarcinoma, Blast Crisis, Blood Protein Disorders, +82 more
- Locations
-
- Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
Completed
Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)
NCT00005626
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT00110045
- Conditions
- Adnexal Diseases, Amyloidosis, Ataxia, +137 more
- Locations
-
- CHU Liege - Domaine Universitaire du Sart Tilman Liège, Belgium
- Centre Hospitalier Universitaire Henri Mondor Créteil, France
- Hopital Edouard Herriot - Lyon Lyon, France
- Hopital Saint-Louis Paris, France